SX-682 is an orally available allosteric inhibitor of CXCR1 and CXCR2 that blocks tumor myeloid suppressor cell recruitment and enhances T cell activation and anti-tumor immunity, with the potential to treat castration-resistant prostate cancer.
Molecular Weight:
467.2
Purity:
98.19%
CAS Number:
[1648843-04-2]
Formula:
C19H14BF4N3O4S
Target:
CXCR
T8497
* VAT and and shipping costs not included. Errors and price changes excepted